Nadofaragene firadenovec Disease Interactions
There is 1 disease interaction with nadofaragene firadenovec.
Nadofaragene firadenovac (applies to nadofaragene firadenovec) immunosuppression
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
Nadofaragene firadenovac is a non-replication adenoviral vector-based gene therapy. Patients who are immunocompromised or immunodeficient may be at risk for disseminated adenovirus infection. Avoid exposure to this drug in those patients.
Switch to professional interaction data
Nadofaragene firadenovec drug interactions
There are 309 drug interactions with nadofaragene firadenovec.
Report options
More about nadofaragene firadenovec
- nadofaragene firadenovec consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Enfortumab vedotin
Enfortumab vedotin systemic is used for bladder cancer, urothelial carcinoma
Mitomycin
Mitomycin systemic is used for anal cancer, bladder cancer, pancreatic cancer, stomach cancer ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
